Immunological Responses in Intra-Abdominal Infections and Progression to Sepsis

Overview

Complicated intra-abdominal infection (cIAI) is a frequent surgical emergency that can rapidly progress to intra-abdominal sepsis (IAS), leading to early organ dysfunction and high mortality. This review highlights the specialized immune compartment of the peritoneal cavity and its role in initial infection containment and subsequent systemic inflammatory escalation driving disease progression.

Background

Intra-abdominal infections (IAIs) involve infection of the peritoneal cavity or abdominal organs and are classified as uncomplicated or complicated (cIAI) based on infection spread. cIAI often arises from gastrointestinal perforations or postoperative infections and requires urgent surgical and antimicrobial management. Despite treatment, many patients progress to IAS, characterized by systemic inflammation, organ dysfunction, and poor outcomes. The peritoneal cavity contains specialized immune cells and structures that mount rapid local responses but may also contribute to systemic sepsis if local containment fails.

Data Highlights

Key Findings

• The peritoneal cavity is an immunologically active compartment containing resident macrophages, B1 cells, innate lymphoid cells, and fat-associated lymphoid clusters (milky spots).
• These immune components enable rapid, high-intensity local inflammatory responses to contain polymicrobial intra-abdominal infections initially.
• Failure or delay in intervention, along with host factors like age and immunosuppression, can lead to excessive inflammation and peritoneal barrier breakdown.
• Pathogen and injury signals then disseminate systemically via vascular and lymphatic routes, driving progression from cIAI to IAS.
• IAS is associated with early organ dysfunction, hemodynamic instability, and markedly increased mortality.
• Understanding compartment-specific immune dynamics may enable earlier risk stratification and immunologically informed treatment strategies.

Clinical Implications

Clinicians should recognize the peritoneal cavity as an active immune compartment whose dysregulation can precipitate systemic sepsis. Early and adequate source control combined with timely antimicrobial therapy remains critical to prevent progression. Incorporating immunological insights into patient stratification may improve outcomes by guiding more precise, individualized interventions across the cIAI–IAS spectrum.

Conclusion

The compartmentalized immune responses within the peritoneal cavity critically influence the clinical trajectory of intra-abdominal infections. Advancing understanding of these mechanisms offers potential to enhance early risk assessment and optimize management strategies to reduce progression to severe sepsis and improve patient outcomes.

References

1. Global Alliance for Infections in Surgery & World Society of Emergency Surgery (GAIS/WSES) Consensus -- Classification and Management of Intra-Abdominal Infections
2. WISS (WSES cIAI Score) Study -- Mortality and Sepsis Severity in cIAI
3. Epidemiological Studies on Sepsis Sources -- cIAI as a Leading Cause of Sepsis